We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-4.34%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.36B
AUM Growth
-$69.4M
Cap. Flow
+$3.35M
Cap. Flow %
0.25%
Top 10 Hldgs %
30.61%
Holding
196
New
3
Increased
43
Reduced
80
Closed
7

Top Buys

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$7.15M
2
GE icon
GE Aerospace
GE
+$6.53M
3
PYPL icon
PayPal
PYPL
+$2.69M
4
DIS icon
Walt Disney
DIS
+$1.7M
5
CB icon
Chubb
CB
+$1.44M

Top Sells

Rank Stock Value
1
WLY icon
John Wiley & Sons Class A
WLY
+$4.49M
2
BLKB icon
Blackbaud
BLKB
+$3.79M
3
USB icon
US Bancorp
USB
+$3.5M
4
MTB icon
M&T Bank
MTB
+$2.9M
5
MSFT icon
Microsoft
MSFT
+$1.57M

Sector Composition

Rank Sector Weight
1 Technology 27.55%
2 Healthcare 18.31%
3 Industrials 14.05%
4 Financials 9.97%
5 Materials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
26
Sanofi
SNY
$109B
$20.2M 1.48%
376,378
+5,055
+1% +$270K
TRMB icon
27
Trimble
TRMB
$13.6B
$19.7M 1.45%
365,403
+21,292
+6% +$1.13M
PYPL icon
28
PayPal
PYPL
$50.3B
$19.7M 1.45%
336,458
+41,283
+14% +$2.69M
WY icon
29
Weyerhaeuser
WY
$17.7B
$19.4M 1.42%
632,044
+13,690
+2% +$451K
CVX icon
30
Chevron
CVX
$374B
$19.3M 1.42%
114,361
+1,685
+1% +$272K
DIS icon
31
Walt Disney
DIS
$172B
$17.6M 1.29%
217,138
+19,886
+10% +$1.7M
MDT icon
32
Medtronic
MDT
$111B
$17.5M 1.28%
222,963
+535
+0.2% +$44.8K
AAPL icon
33
Apple
AAPL
$4.99T
$17.4M 1.28%
101,790
-467
-0.5% -$85.6K
PG icon
34
Procter & Gamble
PG
$347B
$17.3M 1.27%
118,434
-633
-0.5% -$96.7K
JNJ icon
35
Johnson & Johnson
JNJ
$643B
$16.5M 1.22%
106,238
+269
+0.3% +$44.4K
PPG icon
36
PPG Industries
PPG
$26.5B
$16.1M 1.18%
123,881
+269
+0.2% +$37.8K
SHEL icon
37
Shell
SHEL
$238B
$16.1M 1.18%
249,721
+5,836
+2% +$363K
NVS icon
38
Novartis
NVS
$304B
$15.8M 1.16%
155,026
+1,269
+0.8% +$129K
GEHC icon
39
GE HealthCare
GEHC
$29.2B
$15.2M 1.11%
222,850
+98,218
+79% +$7.15M
ZBH icon
40
Zimmer Biomet
ZBH
$18.5B
$14.2M 1.05%
126,816
-528
-0.4% -$67.1K
MTB icon
41
M&T Bank
MTB
$36.6B
$14.2M 1.04%
111,937
-22,204
-17% -$2.9M
DVN icon
42
Devon Energy
DVN
$49.2B
$13.9M 1.02%
292,233
+934
+0.3% +$47K
XOM icon
43
ExxonMobil
XOM
$634B
$12.3M 0.91%
104,861
-2,845
-3% -$312K
AZO icon
44
AutoZone
AZO
$50.9B
$12.3M 0.9%
4,826
+112
+2% +$281K
CTSH icon
45
Cognizant
CTSH
$23.8B
$12.2M 0.9%
180,457
+2,187
+1% +$151K
USB icon
46
US Bancorp
USB
$100B
$11.5M 0.84%
346,357
-96,084
-22% -$3.5M
TDY icon
47
Teledyne Technologies
TDY
$30.1B
$11.4M 0.83%
27,783
+3,075
+12% +$1.25M
GLW icon
48
Corning
GLW
$108B
$11.2M 0.82%
367,132
+2,682
+0.7% +$87.7K
TMO icon
49
Thermo Fisher Scientific
TMO
$214B
$10.4M 0.77%
20,575
-258
-1% -$137K
BRK.A icon
50
Berkshire Hathaway Class A
BRK.A
$1.1T
$9.04M 0.66%
17

Similar funds

Grandfield & Dodd's Q3 2023 Portfolio in Review

As of Q3 2023, Grandfield & Dodd held 196 positions worth $1.36B, down 4.9% from $1.43B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grandfield & Dodd's Q3 2023 filing shows 3 new, 43 increased, 80 reduced and 7 closed positions. Its largest new stake was Lockheed Martin: 538 shares worth $220K. The largest sale was John Wiley & Sons Class A, an estimated $4.49M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q3 2023 buy was Lockheed Martin: 538 shares worth $220K.
  • Grandfield & Dodd added most to GE HealthCare in Q3 2023, an estimated $7.15M increase.
  • Grandfield & Dodd's biggest Q3 2023 reduction was John Wiley & Sons Class A, cutting an estimated $4.49M.
  • Grandfield & Dodd fully exited Dow Inc in Q3 2023, selling an estimated $257K.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $1.36B portfolio in Q3 2023.
  • Grandfield & Dodd opened 3 new positions and closed 7 in Q3 2023.
  • Grandfield & Dodd's portfolio value fell 4.9% quarter-over-quarter to $1.36B.

Based on Grandfield & Dodd's 13F filing for Q3 2023, filed 26 Oct 2023.